Literature DB >> 11196567

Long QT syndrome: cellular basis and arrhythmia mechanism in LQT2.

C T January1, Q Gong, Z Zhou.   

Abstract

LQT2 is one form of the congenital long QT syndrome. It results from mutations in the human ether-a-go-go-related gene (HERG), and more than 80 mutations, usually causing single amino acid substitutions in the HERG protein, are known. HERG encodes the ion channel pore-forming subunit protein for the rapidly activating delayed rectifier K+ channel (I(Kr)) in the heart. This review summarizes current findings about mutations causing LQT2, the mechanisms by which mutations may cause the clinical phenotype of a reduction in I(Kr) and a prolonged QT interval, and how this may be involved in the generation of ventricular arrhythmias.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11196567     DOI: 10.1046/j.1540-8167.2000.01413.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  29 in total

1.  14-3-3 amplifies and prolongs adrenergic stimulation of HERG K+ channel activity.

Authors:  Anna Kagan; Yonathan F Melman; Andrew Krumerman; Thomas V McDonald
Journal:  EMBO J       Date:  2002-04-15       Impact factor: 11.598

Review 2.  Genetic basis for the origin of cardiac arrhythmias: implications for therapy.

Authors:  Mackenzi Mbai; Sridharan Rajamani; Brian P Delisle; Blake D Anson; Corey Anderson; Jonathan C Makielski; Craig T January
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

3.  Drug binding to aromatic residues in the HERG channel pore cavity as possible explanation for acquired Long QT syndrome by antiparkinsonian drug budipine.

Authors:  Eberhard P Scholz; Edgar Zitron; Claudia Kiesecker; Sonja Lueck; Sven Kathöfer; Dierk Thomas; Slawomir Weretka; Simon Peth; Volker A W Kreye; Wolfgang Schoels; Hugo A Katus; Johann Kiehn; Christoph A Karle
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-14       Impact factor: 3.000

4.  Mechanisms of pharmacological rescue of trafficking-defective hERG mutant channels in human long QT syndrome.

Authors:  Qiuming Gong; Melanie A Jones; Zhengfeng Zhou
Journal:  J Biol Chem       Date:  2005-12-16       Impact factor: 5.157

Review 5.  Importance of Knowing the Genotype and the Specific Mutation When Managing Patients with Long QT Syndrome.

Authors:  Arthur J Moss; Ilan Goldenberg
Journal:  Circ Arrhythm Electrophysiol       Date:  2008-08

6.  The G604S-hERG mutation alters the biophysical properties and exerts a dominant-negative effect on expression of hERG channels in HEK293 cells.

Authors:  Jianhua Huo; Yanmin Zhang; Na Huang; Ping Liu; Chen Huang; Xueyan Guo; Wenhui Jiang; Nan Zhou; Andrew Grace; Christopher L H Huang; Aiqun Ma
Journal:  Pflugers Arch       Date:  2008-04-03       Impact factor: 3.657

Review 7.  How do sex hormones modify arrhythmogenesis in long QT syndrome? Sex hormone effects on arrhythmogenic substrate and triggered activity.

Authors:  Katja E Odening; Gideon Koren
Journal:  Heart Rhythm       Date:  2014-06-19       Impact factor: 6.343

8.  Sequence of gating charge movement and pore gating in HERG activation and deactivation pathways.

Authors:  Samuel J Goodchild; Logan C Macdonald; David Fedida
Journal:  Biophys J       Date:  2015-03-24       Impact factor: 4.033

9.  Long QT syndrome: from channels to cardiac arrhythmias.

Authors:  Arthur J Moss; Robert S Kass
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

10.  The Fast Component of hERG Gating Charge: An Interaction between D411 in the S1 and S4 Residues.

Authors:  Ying Dou; Logan C Macdonald; Yue Wu; David Fedida
Journal:  Biophys J       Date:  2017-11-07       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.